Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 21Unknown 15Terminated 4

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × titanium silicide × Clear all
NCT02191566 2022-12-08

SOHUG

Kangbuk Samsung Hospital

Phase 2 Terminated
8 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00429858 2020-09-18

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

University of California, San Francisco

Phase 2 Terminated
21 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

NCT01980810 2016-06-14

GC-A-003

ChineseAMS

Phase 2 Terminated
36 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01096745 2011-06-23

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Gyeongsang National University Hospital

Phase 2 Terminated
78 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡